237:374-75.
184. Parodi JC, Schönholz C, Parodi FE, Sicard G, Ferreira LM. Initial 200
cases of carotid artery stenting using a reversal of flow cerebral protection device. J Cardiovasc Surg 2007;48:117-24.
185. Schnaudigel S, Gröschel K, Pilgram SM, Kastrup A. New brain lesions
after carotid stenting versus carotid endarterectomy: a systematic
review of the literature. Stroke 2008;39:1911-9.
186. Ansel GM, Hopkins LN, Jaff MR, Rubino P, Bacharach JM, Scheinert
D, Myla S, et al. Safety and efficacy of the INVATEC MOMA proximal
cerebral protection device during carotid artery stenting: results form
the ARMOUR pivotal trial. Catheter Cadiovasc Interv 2010;76:1-8.
187. Hart JP, Peeters P, Verbist J, Deloose K, Bosiers M. Do device
characteristics impact outcome in carotid artery stenting?. J Vasc Surg
2006;44:725-30.
188. Hopkins LN, Roubin GS, Chakhtoura EY, Gray WA, Ferguson RD,
Katzen BT, et al. The Carotid revascularization Endarterectomy versus
stenting trial: credentialing of interventionalists and final results of the
lead-in phase. J Stroke Cerebrovasc Dis 2010;19:153-62.
189. Hobson RW 2nd, Howard VJ, Roubin GS, Ferguson RD, Brott TG,
Howard G, et al. Credentialing of Surgeons as interventionalists for
carotid artery stenting: experience from the lead-in phase of CREST. J
Vasc Surg 2004;40:952-7.
190. Verzini F, De Rango P, Parlani G, Panuccio G, Cao P. Carotid artery
